Corvus Pharmaceuticals Inc (NASDAQ:CRVS)
| 4.45 Delayed Data As of Sep 18 |  -0.05 / -1.11%Today’s Change | 1.01 Today|||52-Week Range 6.88 | -18.20% Year-to-Date |
Latest CRVS News | Press Releases
| Corvus Pharma +10% on encouraging CPI-006 data in COVID-19 Sep 10 / Seeking Alpha - Paid Partner Content |
Today’s Trading
| Previous close | 4.50 |
| Today’s open | 4.49 |
| Day’s range | 4.45 - 4.63 |
| Volume | 8,486 |
| Average volume (3 months) | 1,526,705 |
| Market cap | $124.8M |
Data as of 3:59pm ET, 09/18/2020
Growth & Valuation
| Earnings growth (last year) | +6.80% |
| Earnings growth (this year) | +20.75% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 1.75 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| GRTSGritstone Oncology I... | -0.05 | -1.50% |
| PTNPalatin Technologies... | +0.01 | +1.08% |
| TYMETyme Technologies In... | 0.00 | 0.00% |
| LUMOLumos Pharma Inc | -0.07 | -0.48% |
Data as of 4:00pm ET, 09/18/2020
Financials
| Next reporting date | October 29, 2020 |
| EPS forecast (this quarter) | -$0.24 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$46.7M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Burlingame, California |
Forecasts
